Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson’s Disease

BACKGROUND: Mood disorders are very frequent in Parkinson’s Disease (PD), and their effective treatment is still a major unresolved issue: growing evidence suggests that glutamatergic system dysfunction is directly involved. Safinamide is a drug with an innovative mechanism of action, dopaminergic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cattaneo, Carlo, Müller, Thomas, Bonizzoni, Erminio, Lazzeri, Gabriele, Kottakis, Ioannis, Keywood, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676861/
https://www.ncbi.nlm.nih.gov/pubmed/28777756
http://dx.doi.org/10.3233/JPD-171143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676861/
https://www.ncbi.nlm.nih.gov/pubmed/28777756
http://dx.doi.org/10.3233/JPD-171143

Ejemplares similares